LONA
LeonaBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.61
−4.89%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.69
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.80
- EPS estimate
- -$1.39
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -323.1%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $16
- PT range
- $15 – $17
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$1.39 | -$0.80 | Beat 42.40% | — |
| May 7, 2026 | -$2.28 | -$1.73 | Beat 24.03% | — |
| Mar 26, 2026 | -$1.35 | -$19 | Miss -1300.34% | — |
| Nov 6, 2025 | -$1.06 | -$1.68 | Miss -58.49% | — |
| Aug 7, 2025 | -$1.80 | -$1.80 | In line | — |
| May 9, 2025 | -$0.20 | -$0.23 | Miss -15.00% | — |
| Feb 27, 2025 | -$0.23 | -$0.39 | Miss -69.57% | — |
| Nov 7, 2024 | -$0.80 | -$0.75 | Beat 6.25% | — |
| Aug 1, 2024 | -$0.75 | -$0.70 | Beat 6.67% | — |
| May 15, 2024 | -$0.80 | -$0.69 | Beat 13.75% | — |
| Feb 22, 2024 | -$0.96 | -$0.71 | Beat 26.04% | $1.7M |
| Nov 9, 2023 | -$0.87 | -$0.87 | In line | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026